COMMUNIQUÉS West-GlobeNewswire

Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress

23/09/2019 - 07:00

First positive results from a Phase III cancer immunotherapy combination study in people with previously untreated advanced bladder cancer First results from the BFAST study testing Foundation Medicine’s FoundationOne® [...]

BeiGene Announces Clinical Results on Tislelizumab Presented at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)

23/09/2019 - 01:00

BEIJING, China and CAMBRIDGE, Mass., Sept. 22, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Oncology Venture presents positive data at ESMO on DRP as a response predictor for 5-FU treatment in colorectal cancer

23/09/2019 - 00:05

Press release Hoersholm, Denmark, September 23, 2019 – Oncology Venture A/S (Nasdaq First North Growth Market Stockholm: OV.ST) today announces that data on the ability of DRP ® to predict response to 5-FU anti-cancer [...]

XBiotech annonce l’octroi d’un brevet canadien pour le traitement des pathologies dermatologiques

21/09/2019 - 15:41

AUSTIN, Texas, 21 sept. 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui que l’Office canadien des brevets lui avait octroyé un brevet (brevet n°56003542-6CA) couvrant l’utilisation du [...]

Whole Biome Announces Corporate Name Change to Pendulum Therapeutics

21/09/2019 - 00:00

SAN FRANCISCO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Whole Biome, an evidence-based microbiome company, announced today that it is changing its corporate name to Pendulum Therapeutics. The name change reflects the company’ [...]

Innate Pharma annonce le dépôt d’un document d’enregistrement Form-F1 en vue de son introduction en bourse envisagée aux Etats-Unis et le dépôt d’un Document d’Enregistrement Universel

20/09/2019 - 23:30

Marseille, France, le 20 septembre 2019, 23:30 INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (« Innate » ou la « Société »), une société de biotechnologie française spécialisée dans la découverte, le [...]

Innate Pharma files registration statement for proposed initial public offering in the United States

20/09/2019 - 23:30

Marseille, France, September 20, 2019 INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“ Innate ” or the “ Company ”), a French biotechnology company focused on discovering, developing and commercializing [...]

KemPharm Provides Updates Regarding its Board of Directors

20/09/2019 - 23:00

CELEBRATION, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that, on [...]

Invitation to the special and extraordinary shareholders' meetings

20/09/2019 - 22:53

Mechelen, Belgium; 20 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) invites its shareholders to a special and extraordinary shareholders' meeting. On 14 July 2019, [...]

IGM Biosciences Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

20/09/2019 - 22:05

MOUNTAIN VIEW, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) today announced the closing of its initial public offering of 12,578,125 shares of its common stock at a price to the public [...]

Invitation to the special and extraordinary shareholders' meetings

20/09/2019 - 22:01

Mechelen, Belgium; 20 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) invites its shareholders to a special and extraordinary shareholders' meeting. On 14 July 2019, [...]

Emisphere Development Update

20/09/2019 - 18:31

ROSELAND, N.J., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk announced today the Federal Food and Drug Administration (FDA) has approved Rybelsus, a semaglutide tablet, for the treatment of adults with type 2 [...]

AVRA Medical Robotics Appoints Two World Renowned Professionals to Chair its Medical and Scientific Advisory Boards

20/09/2019 - 17:25

ORLANDO, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), an emerging company which is building a fully autonomous medical robotic system through the use of new [...]

Healthcare Special Opportunities Fund Announces September 2019 Quarterly Distribution

20/09/2019 - 17:10

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- ( TSX: MDS.UN ) – LDIC Inc. (the “ Manager ”), the manager of Healthcare Special [...]

Rybelsus® (semaglutide tablets), the first GLP-1 in a tablet approved in the US

20/09/2019 - 17:04

Bagsværd, Denmark, 20 September 2019 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Rybelsus ® (semaglutide tablets), as an adjunct to diet and exercise to improve glycaemic [...]

BriaCell Announces Private Placement of up to $600,000

20/09/2019 - 17:03

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 20, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]

Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete

20/09/2019 - 17:03

Retirement of Pool shares will be Reflected in 31.9% reduction in Outstanding Shares MIRAMAR, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www. [...]

Aeterna Zentaris Announces Pricing of Approximately $5.0 Million Registered Direct Offering

20/09/2019 - 17:00

CHARLESTON, S.C., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a specialty biopharmaceutical company engaged in commercializing novel pharmaceutical [...]

Coherus BioSciences Announces New Employment Inducement Grants

20/09/2019 - 15:30

REDWOOD CITY, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective September 19, 2019, the compensation committee of the company’s board of directors [...]